Ionis Pharmaceuticals, Inc. (IONS) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Ionis (IONS) Q2 2026: Commercial Revenue Jumps 15% as Tringolza SHTG Launch Expands Market Reach
  July 29, 2026
• IONIS (IONS) Q1 2026: Olazarsen Peak Sales Raised 50% to $3B, Anchoring Commercial Expansion
  April 29, 2026
• IONIS (IONS) Q4 2025: Olazarsen Peak Revenue Raised Above $2B as Launch Readiness Accelerates
  February 25, 2026
• Ionis (IONS) Q3 2025: Tringolza Sales Jump 70% as Blockbuster Launches Take Shape
  October 29, 2025
• Ionis (IONS) Q2 2025: Tringolza Triples Sales, Sets Stage for 3 Launches and $100M Guidance Hike
  July 30, 2025
• Ionis (IONS) Q1 2025: Revenue Guidance Raised 20% as Tringolza Launch Exceeds Early Expectations
  July 04, 2025

Browse all companies